Regencell Bioscience: Cutting Costs Isn't Growth, It's Survival [Seeking Alpha]
Regencell Bioscience Holdings Limited - Ordinary Shares (RGC)
Last regencell bioscience holdings limited - ordinary shares earnings: 10/24 04:10 pm
Check Earnings Report
US:NYSE Investor Relations:
investor.regmovies.com
Company Research
Source: Seeking Alpha
RGC's liquidity is precarious, with cash on hand covering only a few months of runway and substantial doubt about its ability to continue as a going concern. Operating improvements stem from cost-cutting rather than scientific or commercial milestones, with reduced spending on marketing and R&D due to downsizing. The DOJ is investigating RGC's trading and operations, introducing significant legal risk and potential for ongoing material expenses. xijian/E+ via Getty Images Thesis Regencell Bioscience Holdings Limited (NASDAQ: RGC is a Hong Kong–based, early-stage bioscience company that researches, develops, and plans to commercialize Traditional Chinese Medicine formulations, mainly focused at treating neurocognitive disorders like ADHD and autism This article was written by Analyst's Disclosure: I/we have no stock, option or similar derivative position in any of the companies mentioned, and no plans to initiate any such positions within the next 72 hours. I wrote this
Show less
Read more
Impact Snapshot
Event Time:
RGC
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
RGC alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
RGC alerts
High impacting Regencell Bioscience Holdings Limited - Ordinary Shares news events
Weekly update
A roundup of the hottest topics
RGC
News
- S&P 500 Futures Fall in Premarket Trading; Regencell Bioscience, Kratos Defense & Sec Lead [Barron's]Barrons
- S&P 500 Futures Rise in Premarket Trading; Regencell Bioscience, Weatherford Intl Lead [Barron's]Barrons
- Regencell Bioscience (NASDAQ:RGC) had its "sell (e+)" rating reaffirmed by analysts at <a style="font-weight:bold" href="https://weissratings.com/">Weiss Ratings</a>.MarketBeat
- S&P 500 Futures Flat in Premarket Trading; Regencell Bioscience, AngloGold Ashanti Lead [Barron's]Barrons
- Top 10 healthcare stocks according to YTD performance, as the sector holds steady [Seeking Alpha]Seeking Alpha